Skip to main content

Table 3 Candidate BM association with steroid HR and HER2 status in IBC

From: Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ

Candidate BM Clinical marker OR 95% P-value
IGF-IR ER 1.44 0.92-2.26 0.11
PR 2.09 1.29-3.38 0.003 a
HER2 0.94 0.56-1.56 0.81
Rap1 ER 1.85 1.09-3.17 0.024
PR 1.86 1.14-3.05 0.014
HER2 1.17 0.73-1.89 0.81
Vav2 ER 1.09 0.71-1.67 0.69
PR 1.17 0.78-1.76 0.46
HER2 0.96 0.58-1.60 0.88
  1. aassociations between markers found to be significant are in bold.